, Tracking Stock Market Picks
Enter Symbol:
Enanta Pharmaceuticals Inc. (ENTA) [hlAlert]

up 105.22 %

Enanta Pharmaceuticals Inc. (ENTA) rated Outperform by Leerink Swann

Posted on: Monday,  Apr 15, 2013  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Enanta Pharmaceuticals Inc. (NASDAQ: ENTA) on 04/15/2013, when the stock price was $20.48.
Since then, Enanta Pharmaceuticals Inc. has gained 105.22% as of 01/27/2016's recent price of $42.03.
If you would have followed this Leerink Swann 's recommendation on ENTA, you would have gained 105.22% of your investment in 1017 days.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/15/2013 8:25 AM Buy
as of 12/13/2013
1 Week up  34.05 %
1 Month up  82.33 %
3 Months up  94.65 %
1 YTD up  81.44 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy